Should anyone with Philadelphia chromosome-positive ALL who is negative for minimal residual disease receive a hematopoietic stem cell transplant in first remission?

Mark R. Litzow

Research output: Contribution to journal › Review article › peer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Should anyone with Philadelphia chromosome-positive ALL who is negative for minimal residual disease receive a hematopoietic stem cell transplant in first remission?'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds